The Valley Desk

NCT04043455 · Interventional trial

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)

Overall registry status Terminated

Phase 2

Conditions Irritable Bowel Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov